Ego Seeman
Department of Endocrinology and Medicine
Austin Health
University of Melbourne
Melbourne
Australia
Name/email consistency: high
- Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly. Seeman, E. J. Bone Miner. Res. (2010)
- Rebuilding Humpty Dumpty with a serotonin inhibitor. Seeman, E. Nat. Med. (2010)
- Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Seeman, E., Boonen, S., Borgström, F., Vellas, B., Aquino, J.P., Semler, J., Benhamou, C.L., Kaufman, J.M., Reginster, J.Y. Bone (2010)
- Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. Seeman, E., Delmas, P.D., Hanley, D.A., Sellmeyer, D., Cheung, A.M., Shane, E., Kearns, A., Thomas, T., Boyd, S.K., Boutroy, S., Bogado, C., Majumdar, S., Fan, M., Libanati, C., Zanchetta, J. J. Bone Miner. Res. (2010)
- Evidence that calcium supplements reduce fracture risk is lacking. Seeman, E. Clin. J. Am. Soc. Nephrol (2010)
- Festschrift to honor Professor Pierre D. Delmas. Seeman, E., Lindsay, R., Kanis, J.A. Osteoporos. Int (2009)
- To stop or not to stop, that is the question. Seeman, E. Osteoporos. Int (2009)
- Bone modeling and remodeling. Seeman, E. Crit. Rev. Eukaryot. Gene Expr. (2009)
- Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. Seeman, E., Devogelaer, J.P., Lorenc, R., Spector, T., Brixen, K., Balogh, A., Stucki, G., Reginster, J.Y. J. Bone Miner. Res. (2008)
- Bone quality: the material and structural basis of bone strength. Seeman, E. J. Bone Miner. Metab. (2008)
- Structural basis of growth-related gain and age-related loss of bone strength. Seeman, E. Rheumatology. (Oxford) (2008)
- The periosteum--a surface for all seasons. Seeman, E. Osteoporos. Int (2007)
- Non-compliance: the Achilles' heel of anti-fracture efficacy. Seeman, E., Compston, J., Adachi, J., Brandi, M.L., Cooper, C., Dawson-Hughes, B., Jönsson, B., Pols, H., Cramer, J.A. Osteoporos. Int (2007)
- Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?. Seeman, E. Bone (2007)
- Anti-vertebral fracture efficacy of raloxifene: a meta-analysis. Seeman, E., Crans, G.G., Diez-Perez, A., Pinette, K.V., Delmas, P.D. Osteoporos. Int (2006)
- Hot stuff--can't get enough. Seeman, E. Osteoporos. Int (2006)
- Bone quality--the material and structural basis of bone strength and fragility. Seeman, E., Delmas, P.D. N. Engl. J. Med. (2006)
- Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. Seeman, E., Vellas, B., Benhamou, C., Aquino, J.P., Semler, J., Kaufman, J.M., Hoszowski, K., Varela, A.R., Fiore, C., Brixen, K., Reginster, J.Y., Boonen, S. J. Bone Miner. Res. (2006)
- Bone fragility in men--where are we?. Seeman, E., Bianchi, G., Khosla, S., Kanis, J.A., Orwoll, E. Osteoporos. Int (2006)
- Preventing fractures--how good are we really?. Seeman, E. Nature Clinical Practice. Endocrinology & Metabolism (2006)
- Diet and exercise during growth have site-specific skeletal effects: a co-twin control study. Iuliano-Burns, S., Stone, J., Hopper, J.L., Seeman, E. Osteoporos. Int (2005)
- Loading and bone fragility. Seeman, E. J. Bone Miner. Metab. (2005)
- 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Seeman, E., Eisman, J.A. Med. J. Aust. (2004)
- The growth and age-related origins of bone fragility in men. Seeman, E. Calcif. Tissue Int. (2004)
- Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Seeman, E. Curr. Osteoporos. Rep (2004)
- The structural and biomechanical basis of the gain and loss of bone strength in women and men. Seeman, E. Endocrinol. Metab. Clin. North Am. (2003)
- Pathogenesis of bone fragility in women and men. Seeman, E. Lancet (2002)
